Skip to content

Validation of an integrated platform for early warning and intervention of elderly awareness/cognitive impairment assessment Part II:Clinical efficacy and mechanism of tDCS combined with rTMS in patients with post-stroke cognitive impairment

Validation of an integrated platform for early warning and intervention of elderly awareness/cognitive impairment assessment Part II:Clinical efficacy and mechanism of tDCS combined with rTMS in patients with post-stroke cognitive impairment

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076078
Enrollment
Unknown
Registered
2023-09-25
Start date
2023-09-25
Completion date
Unknown
Last updated
2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-stroke cognitive impairment

Interventions

Regular rehabilitation treatment group:Under the guidance of integrated platform, including general rehabilitation training such as stretch, muscle strength training, joint range of motion training an
As well as timing, orientation, memory training, 30 minutes a day, 5 days a week, a total of 3 weeks of intervention.
Transcranial direct current stimulation group:On the basis of routine training, the patients were treated with tDCS using Transcranial direct-current stimulation equipment from of Wuhan Ireed Medical
The transcranial magnetic stimulation group was repeated:On the basis of routine training, the figure-8 coil of Ired's transcranial magnetic stimulation instrument was used for TMS treatment.Patients

Sponsors

Department of Rehabilitation Medicine, Huashan Hospital Affiliated to Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1.The diagnosis of stroke was based on the diagnostic essentials of major cerebrovascular diseases in China 2019 and confirmed by CT or MRI examination. They were in accordance with the diagnostic criteria of PSCI in the expert consensus on management of poststroke cognitive impairment 2021. 2. MMSE<24(high school and above education). MMSE<20(primary school education). MMSE<17(illiteracy). or MOCA< 26. 3.The course of disease was more than 2 weeks and the first stroke was within 6 months 4.Stable vital signs, no severe aphasia, vision, hearing, cognitive impairment, to complete the study program. 5.Age over 60 years old. 6. If cognitive or antidepressant drugs are used, the dose is not adjusted within 1 week; 7. Participate voluntarily and sign informed consent.

Exclusion criteria

Exclusion criteria: 1.Previous history of brain diseases other than cerebrovascular diseases, such as brain trauma, chronic head injury, brain infection, etc. 2.Implants of metal or electronic devices such as artificial pacemaker, cochlear implants, deep brain stimulators, aneurysm clips, post-ventriculoperitoneal shunt internal fixation devices, etc. 3.Unstable heart disease, hypertension and other serious diseases that may affect the study. 4.severe aphasia, visual and hearing impairment. 5.patients with cognitive impairment due to other causes before stroke, 6. Patients with contraindications to RTMS or tDCS.

Design outcomes

Primary

MeasureTime frame
Montreal Cognitive Assessment, MoCA;Mini-mental State Examination, MMSE;

Secondary

MeasureTime frame
activities of daily living, ADL;Depression status/degree;brain function;

Countries

China

Contacts

Public ContactYulong Bai

Department of Rehabilitation Medicine, Huashan Hospital Affiliated to Fudan University

dr_baiyl@fudan.edu.cn+86 135 0197 4457

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026